News
-
Alexza Pharmaceuticals and Spanish pharmaceutical company Grupo Ferrer International have formed a partnership to register, distribute, and promote the Adasuve Staccato loxapine inhaler for the treatment of agitation in patients with schizophrenia or bipolar disorder… Read more . . .
-
King’s College London will be the site of Phase 2 trials of Lightlake Therapeutics’s opioid antagonist-based nasal spray treatment for bulimia nervosa, the company has announced. Lightlake currently has Phase 2 trials underway in Finland… Read more . . .
-
Inhaler manufacturers who have been purchasing acrylonitrile butadiene styrene (ABS) for inhaler housings from either BASF or Ineos will now have a new supplier: Styrolution. Ineos’s Lustran, Novodur, and Absolac brands and BASF’s Terluran brand… Read more . . .
-
Swiss vaccine developer Mymetics Corporation has reclaimed an intranasal influenza vaccine that it had licensed to Solvay prior to Solvay’s acquisition by Abbott Laboratories. Solvay had conducted a Phase 1 trial that found the vaccine… Read more . . .
-
Job Title: DPI Analytical Senior Scientist Organization Unit: R&D – CMC – Strategic Product Enhancement The client, a global multinational company headquartered in Italy, is seeking an enthusiastic and self-motivated individual who would be interested… Read more . . .
-
Novartis Pharmaceuticals Canada has announced that the Québec provincial government will now provide reimbursement for the TOBI Podhaler tobramycin DPI for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis patients.The company cites data from… Read more . . .
-
Only about a month after entering the nasal delivery device market, Bespak has announced a second contract for development of an intranasal device. The company says that “a major global manufacturer of generic medicines” has… Read more . . .
-
Teva Respiratory has announced that it will provide assistance to patients affected by the impending phase out of the OTC Primatene Mist epinephrine inhaler. In addition to providing educational resources, the company says that it… Read more . . .
-
Submit proposals for short courses, roundtables, symposia, mini-symposia, and sunrise sessions at http://abstracts.aapspharmaceutica.com/aaps2012/login.asp by November 7, 2011. For any additional information, contact Bethany Daniel. Read more . . .
-
A Phase 1 clinical trial of a novel dry powder intranasal vaccine for prevention of the H5N1 influenza strain demonstrated that the product was well tolerated, and no serious adverse events occurred, according to developer… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland